.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Covington
Cantor Fitzgerald
Novartis
QuintilesIMS
Chubb
US Army
Julphar
Medtronic

Generated: December 12, 2017

DrugPatentWatch Database Preview

Prazosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prazosin hydrochloride and what is the scope of prazosin hydrochloride freedom to operate?

Prazosin hydrochloride
is the generic ingredient in three branded drugs marketed by Pfizer, Am Therap, Dava Pharms Inc, Idt Australia Ltd, Mylan, Purepac Pharm, Teva Pharms, and Watson Labs, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for prazosin hydrochloride. Thirteen suppliers are listed for this compound.

Pharmacology for prazosin hydrochloride

Medical Subject Heading (MeSH) Categories for prazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Am TherapPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072784-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072333-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Dava Pharms IncPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072707-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072575-003May 16, 1989ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072352-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Idt Australia LtdPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072577-003May 16, 1989RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072609-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Purepac PharmPRAZOSIN HYDROCHLORIDEprazosin hydrochlorideCAPSULE;ORAL072991-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: prazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 1992► Subscribe► Subscribe
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 1992► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 1992► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 1992► Subscribe► Subscribe
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 1992► Subscribe► Subscribe
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Argus Health
Deloitte
McKesson
Farmers Insurance
Fish and Richardson
Colorcon
UBS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot